19 Nov, 2024 Reasons to be cheerful: 4 takeaways from the BIA UK Life Sciences Regulatory Conference 2024 By Hugo Kent-Egan We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...
14 Nov, 2024 The scope of the jurisdiction of the UPC By Richard Pinckney In Aim Sport v Supponor the UPC Court of Appeal handed down a decision focused on the transitional provisions and the scope of the...
13 Nov, 2024 Licensing content to train AI - essential points to consider By Emily Ryder The licensing of content for AI model training is on the rise. Amid reports that developers are facing a scarcity of content to train AI...
11 Nov, 2024 Priority Review Vouchers: another high value sale generates a significant return for licensor By Ellen Lambrix Luca Cericola On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...
06 Nov, 2024 Podcast: EU AI Act - impact on contracts and deals By Camille Beckmann Vik Khurana Anneke Pol In this episode, Camille Beckmann speaks to Anneke Pol and Vik Khurana (along with a special guest AI chatbot!) on how to structure...
05 Nov, 2024 Early Christmas present: MHRA consultation on international recognition of devices By Hugo Kent-Egan The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...
01 Nov, 2024 Irides: Weekly patent litigation update By Liz Cohen Myles Jelf Chloe Dickson Rebecca Daramola Eden Winlow +2 more... Show less The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...
30 Oct, 2024 The first naked anti-TROP2 antibody progresses to a Phase 1/2a clinical trial By Matthew Warren Luca Cericola James Johnston On 24 October 2024, Cancer Research UK ("CRUK") and KisoJi Biotechnology Inc. ("KBI") announced that they have entered into an agreement...
30 Oct, 2024 Further revisions to the MDR and IVDR By Alex Denoon Last week, the European Parliament (EP) passed a resolution calling on the European Commission (EC) to further revise the Medica Devices...
28 Oct, 2024 Split poly(A) tail mRNA patents invalid for insufficiency and obviousness By Kate O'Sullivan This article was first published in Kluwer Patent Blog [October 2024]. On 8 October 2024, Mr Justice Meade handed down judgment in...
28 Oct, 2024 GDPR and scientific research in the UK: what does the Data (Use and Access) Bill have to say? By Mac Macmillan Back in July I speculated, based on the King's Speech, that the new government's proposals for scientific research were likely to be a...
25 Oct, 2024 Irides: Weekly patent litigation update By Brian Cordery James Boon Katie Cambrook Ewan MacAulay Amy Howlett +2 more... Show less The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...